Company Advanced Proteome Therapeutics Corporation

Equities

APC.H

CA0076282098

Investment Holding Companies

Delayed Toronto S.E. 02:25:53 05/12/2023 am IST 5-day change 1st Jan Change
0.005 CAD -.--% Intraday chart for Advanced Proteome Therapeutics Corporation -.--% -.--%

Business Summary

Advanced Proteome Therapeutics Corporation is actively seeking additional funds to advance its core technologies for partnering and other potential revenue streams. It is not engaged in any activity.

Managers

Managers TitleAgeSince
Chief Executive Officer 63 16/18/16
Director of Finance/CFO 72 10/09/10
Director/Board Member 56 20/18/20

Members of the board

Members of the board TitleAgeSince
Director/Board Member 59 -
Director/Board Member 56 20/18/20
Director/Board Member 64 21/22/21
Chief Executive Officer 63 16/18/16

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 41,127,080 36,950,363 ( 89.84 %) 0 89.84 %

Shareholders

NameEquities%Valuation
Conation Capital Corp.
6.438 %
2,647,837 6.438 % 15 887 $
546,950 1.330 % 3 282 $
500,000 1.216 % 3 000 $
473,000 1.150 % 2 838 $
W. Catalano
0.7512 %
308,930 0.7512 % 1 854 $

Company contact information

Advanced Proteome Therapeutics Corp.

8337 Eastlake Drive Suite 104

V5A 4W2, Burnaby

+(604) 690-3797

address Advanced Proteome Therapeutics Corporation(APC.H)
  1. Stock Market
  2. Equities
  3. APC.H Stock
  4. Company Advanced Proteome Therapeutics Corporation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW